Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Legendre

Showing results (181-190 of 309) with videos related to

Pageof 31
Sort By:
Advances in Nephrology From the Necker Hospital|January 1, 1994
Strategy of cytomegalovirus infection prevention in renal transplantationC Legendre, C Rouzioux, D Ducloux, et al.
Transplantation Proceedings|October 1, 1991
Cytomegalovirus infections after kidney transplantation: identical risk whether donor or recipient is the virus carrierE Rocha, H H Campos, C Rouzioux, et al.
Journal of Hepatology|July 1, 1993
Immunogenicity of rat hepatocytes in vivo: effect of cholestasis-induced changes in major histocompatibility complex expressionC Arvieux, Y Calmus, P Gane, et al.
Presse Medicale (Paris, France : 1983)|November 27, 1991
[Hepatitis C in kidney recipients. Epidemiology and impact on kidney transplantation]S Pol, C Legendre, C Saltiel, et al.
Journal of Hepatology|May 1, 1992
Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantationS Pol, C Legendre, C Saltiel, et al.
The New England Journal of Medicine|September 20, 1997
Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplantC Legendre, S Caillat-Zucman, D Samuel, et al.
Annales De Chirurgie|March 27, 2003
[Preoperative selective embolization allowing a partial splenectomy for splenic hamartoma]F Mignon, S Brouzes, D L Breitel, et al.
Transplantation Proceedings|November 15, 2002
Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxisD Anglicheau, A Lautrette, C Scieux, et al.
Therapie|May 1, 1987
[Hepatic involvement due to nifedipine. Description of a case and review of the literature]M Biour, J D Grange, J C Barbare, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 5, 2011
Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trialsD C Brennan, C Legendre, D Patel, et al.
Pageof 31

Showing results (181-190 of 309) with videos related to

Sort By:
Pageof 31
Advances in Nephrology From the Necker Hospital|January 1, 1994
Strategy of cytomegalovirus infection prevention in renal transplantationC Legendre, C Rouzioux, D Ducloux, et al.
Transplantation Proceedings|October 1, 1991
Cytomegalovirus infections after kidney transplantation: identical risk whether donor or recipient is the virus carrierE Rocha, H H Campos, C Rouzioux, et al.
Journal of Hepatology|July 1, 1993
Immunogenicity of rat hepatocytes in vivo: effect of cholestasis-induced changes in major histocompatibility complex expressionC Arvieux, Y Calmus, P Gane, et al.
Presse Medicale (Paris, France : 1983)|November 27, 1991
[Hepatitis C in kidney recipients. Epidemiology and impact on kidney transplantation]S Pol, C Legendre, C Saltiel, et al.
Journal of Hepatology|May 1, 1992
Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantationS Pol, C Legendre, C Saltiel, et al.
The New England Journal of Medicine|September 20, 1997
Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplantC Legendre, S Caillat-Zucman, D Samuel, et al.
Annales De Chirurgie|March 27, 2003
[Preoperative selective embolization allowing a partial splenectomy for splenic hamartoma]F Mignon, S Brouzes, D L Breitel, et al.
Transplantation Proceedings|November 15, 2002
Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxisD Anglicheau, A Lautrette, C Scieux, et al.
Therapie|May 1, 1987
[Hepatic involvement due to nifedipine. Description of a case and review of the literature]M Biour, J D Grange, J C Barbare, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 5, 2011
Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trialsD C Brennan, C Legendre, D Patel, et al.
Pageof 31